Norway vs Western Asia: Proportion of the target population who received a 3rd dose of
Norway
95.0%
in 2024
Western Asia
62.0%
in 2024
Norway rank
28th
Western Asia rank
26th
Proportion of the target population who received a 3rd dose of over time
- Norway
- Western Asia
How they compare
Norway currently reports 95.0% against 62.0% in Western Asia, a difference of 33.0%.
That makes Norway's figure about 1.5 times Western Asia's.
Across all 17 years both countries report, Norway has been ahead every year.
Norway ranks 28th and Western Asia ranks 26th of 157 countries.
Norway has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Norway | Western Asia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 88.5% | 18.0% | 70.5% | Norway |
| 2010s | 93.0% | 54.7% | 38.3% | Norway |
| 2020s | 95.4% | 55.6% | 39.8% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Norway or Western Asia?
- Norway, at 95.0% against 62.0% in Western Asia as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Norway and Western Asia?
- 33.0%, with Norway ahead.
- How many years of comparable data are there for Norway and Western Asia?
- 17 years are reported by both, from 2008 to 2024.
- How do Norway and Western Asia rank globally for proportion of the target population who received a 3rd dose of?
- Norway ranks 28th and Western Asia ranks 26th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.